| Study | Code | Protocol | Indication |
| ABDOMEN | |||
| CT Abdomen | BCT A01 | CT abdomen | |
| Liver 4 phase | BCT A04 | 4 phase: nc, art, ven, 5 min | HCC 1st time screening or known hyperdense nodules |
| Liver 3 Phase | BCT A05 | 3 phase: art, ven, 5 min | Follow up or screening in HCC patient |
| Liver 2 Phase | BCT A05B | 2 phase: art, ven | |
| Liver 1 phase | BCT A06 | 1 phase: ven | Evaluate for hypovascular mets |
| Pancreatic Mass | BCT A07A | 3 phase: nc, art, ven | Pancreatic neoplasm- 1st evaluation |
| Pancreatic Mass | BCT A07B | 2 phase: art, ven | Pancreatic neoplasm- f/u eval |
| Pancreatitis for necrosis | BCT A09 | 3 phase: nc, art, ven | First evaluation of acute pancreatitis to assess for necrosis. For follow-up, use CT Abdomen and Pelvis w iv contrast |
| ABDOMEN/PELVIS | |||
| CT Abd/pelv | BCT A02 | CT abd/pelv | |
| Hernia | BCT A13 | Abd/pelv w/wo valsalva | R/O hernia |
| Retroperitoneal Hematoma | BCT A14IV | Abd/pelv w/wo valsalva | R/O retroperitoneal hematoma |
| Appendicitis | BCT A03 | Abd/Pelv w/ IV con | R/O Appendicitis (rarely done) |
| CT Colonography | BCT A11 | Prone and supine imaging from dome of diaphragm to pubic symphisis | CT colongraphy |
| CT Enterography | BCT A12 | Oral and IV cont- dome of diaphragm to pubic symphisis | Inflammatory bowel disease. |
| CHEST/ABDOMEN | |||
| CT chest/abd | BCT A16 | CT Chest/Abd | |
| CHEST/ABD/PELV | |||
| CT Chest/Abd/Pelv | BCT A15 | CT Chest/Abd/Pelv | General CAP Survey |
| CHEST | |||
| CT Chest | BCT C01 | CT Chest | |
| Lung Nodule low dose | BCT C02 | CT Chest Low dose | Lung nodule follow up |
| CT PE Protocol | BCT C03 | CTA Pulm Arteries | R/O PE |
| CT Chest high res | BCT C04 | Insp/exp/supine/prone | High res for interstitial lung disease |
| CT Esophogram | BCT C06 | Before/after oral cont | Esophageal leak when no fluoroscopy |
| CTA CHEST | |||
| Coronary Calcium Score | BCT CA04 | Gated, heart to mid ascending aorta | Coronary artery calcifications for ACS risk |
| Pulmonary vein anatomy | BCT CA05 | Venous mapping, gated | Mapping prior to Afib Ablation |
| Custom Gated Chest | BCT CA06 | custom parameters | |
| Venogram pulm vein | BCT CV PV | Venous mapping, gated | Prior to A fib ablation or surgery |
| GU PROTOCOLS | |||
| CT cystogram | BCT G01 | 3 phase: nc.90sec.6min, | Primary eval or post-op bladder canc |
| CT Cystogram (Trauma) – Filled only | 1 phase (filled) | Evaluate for bladder injury, or follow-up of bladder injury (low-dose) | |
| Renal Mass 3 phase | BCT G02 | 3 phase: nc.90sec.6min | Evaluate renal mass |
| Renal Donor 3 phase | BCT G04 | 3 phase: nc.art.split bolus | Live renal kidney donor evaluation |
| IVP <50 yo | BCT G05 | 2 phase: nc.split bolus | Non-traumatic hematuria |
| IVP >50 yo 3 phase | BCT G06 | 3 phase: nc.90sec.10min | Non-traumatic hematuria |
| Urinoma Protocol | Pre and 10 minute delay | Evaluate for collecting system leak in renal trauma (low-dose) | |
| IVP >50 yo 2 phase | BCT G06DE | 3 phase: Virtual nc.90sec.610in | Non-traumatic hematuria |
| KUB noncon | BCT G07 | Noncon KUB | R/O urinary stones |
| Adrenal nodule 3 phase | BCT G08 | 3 phase: nc.60sec.10min | classify adrenal nodule |
| CTA PROTOCOLS | |||
| Aorta CAP Acute Aortic | BCT CVA 01 | 2 phase: nc.art Chest/abd/pelv | acute aortic syndrome (AD, IMH) |
| CTA Aorta CAP | BCT CVA 02 | Arterial Chest/abd/pelv | Aneurysm/Dissection f/u |
| CTA thoracic aorta | BCT CVA 03 | Thoracic aorta arterial phase | Aneurysm/Dissection f/u. Eval for thoracic aortic injury |
| CTA Abdominal aorta | BCT CVA 04 | Abdominal aorta arterial phase | AAA assessment or follow-up. Evaluate visceral vessels for stenosis or aneurysm |
| Double Rule out- thoracic aorta | BCT CVA 05 | Thoraco-abd aorta art phase | Evaluate for PE or thoracic aortic dissection |
| Endograft surv abdominal aorta | BCT CVA 07 | 3 phase: nc.art.2min | Surveillance of endovascular abd. Aortic stent graft |
| Brached edograft research | BCT CVA 08 | 3 phase: nc.art.2min | endograft research protocol Dr. Sweet (UWMC) |
| Abd-Pelv mesenteric isch | BCT CVA09 | 2 phase: abd/pelv (art.70s) | Evaluate for bowel or mesenteric ischemia |
| Gastrointestinal Hemorrhage | BCT CVA09B | 3 phase: nc.art.2min | Evaluate for GI Hemorrhage |
| Periph run off CTA Abd Aorta | BCT CVA 10 | 2 phase: art.delay abd/pelv/feet | Peripheral art disease/absent pulses |
| Aorta ECG Gated CAP | BCT CVA11 | ECG gated CTA chest/abd/pelv | Evaluate for acute aortic syndrome (AD, IMH) |
| fu repair aneurysm or dissection | BCT CVA11N | ||
| Gated thoracic aorta | BCT CVA12 | Aneurysm/Dissection f/u; aortic injur | |
| Abd/pelv for DIEP flap breast recons | BCT CVA 13 | Planning breast reconstruction DIEP | |
| IVC or hepatic vein venogram | BCT CVA14 | 1 phase (2-3 min delayed) | IVC clot or IVC pathology |
| TAVR | BCT CVA15 | Percutaneous AVR | |
| Endograft surv thoracic and abdominal | BCT CVA16 | 3 phase: nc.art.2min | Complications of a TEVAR & EVAR |
| Sudden cardiac death protocol | BCT CVA17 | Thoraco-abd aorta art phase | Eval status post CPR for aortic trauma |
| · Leaving the root protocol code makes the study a noncontrast exam | |||
| o Adding an “O” – Oral contrast ; Add an “IV” IV Contrast ; add “OIV” for oral AND IV contrast | |||
| o Example: BCT 02 is abd/pelv non con; BCT 02IV is abd/pelv cont | |||
| · Adding a DE at the end of the original code makes the study a dual energy examination | |||
| · Adding a U prior to the IV makes the exam ultralow dose | |||
| o BCT 02UIV – abd pelv w/IV contrast, ultralow dose | |||
2017 competency project of Dr. Keegan Hovis and Barun Aryal